Email LinkedIn Twitter


Best Practices in the Professional Organizations & Patient Advocacy Functions


CHAPEL HILL, N.C. – September 3, 2010 – Pharmaceutical companies have historically focused on physicians and pharmacists to drive new product uptake in the marketplace.  Now, however, relationships with patient advocacy groups and professional organizations are proving ever more critical to new product success.  Consequently, pharmaceutical companies' Professional and Advocacy Relations (PAR) functions warrant increased attention and are receiving heightened scrutiny, according to a study by Best Practices, LLC.  
The detailed report provides executives with insights into the methods that leading companies are utilizing to create effective cross-function collaboration. Key topics covered in Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence include:

In the compelling benchmarking report, Patient Advocacy and Professional Organizations: Building Effective Relationships, (available at http://www.best-in-class.com/rr749.htm) top pharmaceutical companies, including Merck, Abbott Labs, Pfizer, AstraZeneca, Wyeth and Eli Lilly broach the multifaceted issues faced by their PAR divisions.  In addition, these industry leaders share myriad patient advocacy best practices such as:

  • Maintain a contact database to track spending across patient advocacy groups and professional associations.
  • Encourage C-level management to attend professional organizational meetings and networking events to cast the company in the public spotlight.  
The Integrated findings from various research studies will provide the executive with a comprehensive report on how to design, cultivate and optimize cross-functional team structures and management across the organization to improve efficiencies, enable knowledge sharing and bring products to market faster.


To learn more, download a complimentary summary of this report at: http://www.best-in-class.com/rr749.htm. For deeper exploration and discussion of the captured data, please contact Dexter Beals at 919-767-9229 or dbeals@best-in-class.com


ABOUT BEST PRACTICES, LLC
Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations.

For more information, call 919-403-0251 or visit http://www.best-in-class.com.


 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information